thalidomide has been researched along with Pulmonary Arterial Remodeling in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide (Thal) has been shown to increase the anti-tumor effect of chemotherapy agents in solid tumors." | 1.51 | Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin. ( Li, S; Liu, P; Shen, Y; Tian, Q; Wang, B; Wang, J; Wang, M; Wang, X; Yang, J, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, Y | 1 |
| Li, S | 1 |
| Wang, X | 1 |
| Wang, M | 1 |
| Tian, Q | 1 |
| Yang, J | 2 |
| Wang, J | 1 |
| Wang, B | 1 |
| Liu, P | 1 |
1 other study available for thalidomide and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Delivery Syste | 2019 |